Two Giants Dominate IHE, Making It Riskier Than It Looks
As of March 2026, the iShares U.S. Pharmaceuticals ETF is heavily keyed to two drugmakers, exposing investors to outs...
What drives stock market index performance includes macro trends, earnings, and valuation shifts. This overview explains the main forces behind movements.
27,569 articlesAs of March 2026, the iShares U.S. Pharmaceuticals ETF is heavily keyed to two drugmakers, exposing investors to outs...
Apple advances a leadership shift, naming hardware chief John Ternus as the next CEO, effective Sept. 1, 2026. Tim Co...
Start your week with smart, practical investing ideas. This 10-item Monday Reads digest breaks down market trends, po...
Oracle’s $523 billion backlog raises timing concerns as capex surges. cnbc’s deirdre bosa warns that the chip upgrade...
Hut 8's stock surged on news of a landmark AI data center deal valued at $9.8 billion, positioning the crypto miner t...
Everus ECG's 2026 earnings story hinges on growing recurring revenue and cash flow turnarounds. This analysis breaks ...
Goldman Sachs raises Enphase Energy's price target to 57 and maintains a Buy rating, highlighting a nascent rebound i...
A biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
Five years after a regulatory shock hit XRP, a $10,000 investment would have swung through a volatile ride. Here’s th...
Nexa delivered an earnings snapshot that matters for 2026. This guide breaks down the numbers, what they mean for gui...
As the fourth quarter wrapped up, foreclosure auctions surged last, signaling rising distress in several markets. Thi...
SpaceX's planned IPO could be the largest ever, drawing Gulf sovereign funds into tech-heavy bets and reshaping globa...